Issues lobbied + lobbyists
MMM — Medicare/Medicaid
Prescription drug pricing issues. Fair Accountability and Innovative Research Drug Pricing Act. H.R. 3789/S. 229 - The Drug-price Transparency for Consumers (DTC) Act of 2025..
Lobbyists: STEPHEN M. COTE; BRUCE MEHLMAN; DEAN ROSEN; mr DAVID R THOMAS; ELISE FINLEY PICKERING; SAGE EASTMAN; LAUREN ARONSON; MICHAEL ROBINSON; HELEN TOLAR; NICHOLE DISTEFANO; PAUL THORNELL; ALEXANDER PERKINS; ROSEMARY GUTIERREZ; ZACHARY MALLOVE; CAITLIN VAN SANT; LISA GOLDMAN; ALYENE MLINAR; ms ERICA JAY CHABOT; ANNIE WOLF; NAVEEN PARMAR; JON ADAME; mr JOSEPH EDWARD BROWN iii; EARL SCOTT FLOOD
Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
PHA — Pharmacy
Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954/H.R. 5526 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 2630 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act H.R.1262 - Mikaela Naylon Give Kids a Chance Act. S. 3014 - Ensuring Timely Access to Generics Act of 2025 S. 1414 - Expedited Access to Biosimilars Act S. 1032/H.R. 1843 - Increasing Transparency in Generic Drug Applications Act
Lobbyists: BRUCE MEHLMAN; DEAN ROSEN; mr DAVID R THOMAS; ELISE FINLEY PICKERING; SAGE EASTMAN; LAUREN ARONSON; MICHAEL ROBINSON; HELEN TOLAR; NICHOLE DISTEFANO; PAUL THORNELL; STEPHEN M. COTE; ALEXANDER PERKINS; ROSEMARY GUTIERREZ; ZACHARY MALLOVE; CAITLIN VAN SANT; LISA GOLDMAN; ALYENE MLINAR; ms ERICA JAY CHABOT; ANNIE WOLF; NAVEEN PARMAR; JON ADAME; mr JOSEPH EDWARD BROWN iii; EARL SCOTT FLOOD
Government entities lobbied: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
CPT — Copyright/Patent/Trademark
Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S. 1097/H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025. S. 43/H.R. 6485 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - Eliminating Thickets to Increase Competition (ETHIC) Act. H.R. 3160/s. 1533 - the Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act.
Lobbyists: BRUCE MEHLMAN; DEAN ROSEN; mr DAVID R THOMAS; ELISE FINLEY PICKERING; SAGE EASTMAN; LAUREN ARONSON; MICHAEL ROBINSON; HELEN TOLAR; NICHOLE DISTEFANO; PAUL THORNELL; STEPHEN M. COTE; ALEXANDER PERKINS; ROSEMARY GUTIERREZ; ZACHARY MALLOVE; CAITLIN VAN SANT; LISA GOLDMAN; ALYENE MLINAR; ms ERICA JAY CHABOT; ANNIE WOLF; NAVEEN PARMAR; JON ADAME; mr JOSEPH EDWARD BROWN iii; EARL SCOTT FLOOD
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
TAX — Taxation/Internal Revenue Code
S. 1785/H.R. 3010 - The No Handouts for Drug Advertisements Act.
Lobbyists: BRUCE MEHLMAN; DEAN ROSEN; mr DAVID R THOMAS; ELISE FINLEY PICKERING; SAGE EASTMAN; LAUREN ARONSON; MICHAEL ROBINSON; HELEN TOLAR; NICHOLE DISTEFANO; PAUL THORNELL; STEPHEN M. COTE; ALEXANDER PERKINS; ROSEMARY GUTIERREZ; ZACHARY MALLOVE; CAITLIN VAN SANT; LISA GOLDMAN; ALYENE MLINAR; ms ERICA JAY CHABOT; ANNIE WOLF; NAVEEN PARMAR; JON ADAME; mr JOSEPH EDWARD BROWN iii; EARL SCOTT FLOOD
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE